论文部分内容阅读
多项流行病学研究揭示了超重/肥胖与T2DM管理的严峻形势。T2DM患者多伴超重/肥胖,随着治疗的强化出现体重增加,对患者影响巨大。2016年ADA、2015年AACE及2013年CDS的指南均进一步强调了体重管理的重要性:建议对超重/肥胖的T2DM患者,通过生活方式、药物和手术等实现体重的有效控制;针对各种药物对体重的影响不同,应选择体重增加少的治疗策略,以预防因治疗带来的体重增加及不良结果;应用胰岛素治疗,需尽量避免或减少体重增加。
A number of epidemiological studies have revealed the severe situation of overweight / obesity and T2DM management. Many patients with T2DM overweight / obesity, with the strengthening of the treatment of weight gain, the impact on patients. The importance of weight management is further emphasized by the 2016 ADA, 2015 AACE and 2013 CDS guidelines: It is recommended that overweight / obese patients with T2DM achieve effective weight control through lifestyles, medications, and surgery; Different effects on body weight, weight gain should be selected less treatment strategies to prevent weight gain due to treatment and adverse outcomes; the application of insulin therapy, the need to avoid or reduce weight gain as much as possible.